SCYNEXIS (SCYX)
(Delayed Data from NSDQ)
$1.51 USD
-0.02 (-1.31%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.52 +0.01 (0.66%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for SCYNEXIS, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 75 | 74 | 104 | 93 | 48 |
Receivables | 0 | 2 | 1 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 1 | 0 | 0 | 0 |
Other Current Assets | 27 | 3 | 4 | 5 | 4 |
Total Current Assets | 102 | 79 | 109 | 98 | 52 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 24 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 1 | 0 | 0 |
Deposits & Other Assets | 0 | 6 | 6 | 1 | 1 |
Total Assets | 128 | 88 | 120 | 103 | 57 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 6 | 8 | 5 | 7 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 8 | 6 | 6 | 4 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 6 | 0 | 18 | 0 |
Total Current Liabilities | 16 | 18 | 14 | 26 | 11 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3 | 0 | 0 | 0 | 0 |
Convertible Debt | 12 | 11 | 12 | 17 | 12 |
Long-Term Debt | 0 | 34 | 29 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 22 | 19 | 21 | 34 | 18 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 55 | 85 | 79 | 80 | 44 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 428 | 425 | 401 | 349 | 284 |
Retained Earnings | -355 | -422 | -359 | -327 | -271 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 73 | 3 | 41 | 23 | 13 |
Total Liabilities & Shareholder's Equity | 128 | 88 | 120 | 103 | 57 |
Total Common Equity | 73 | 3 | 41 | 23 | 13 |
Shares Outstanding | 37.20 | 32.60 | 23.90 | 19.60 | 9.70 |
Book Value Per Share | 1.96 | 0.10 | 1.73 | 1.16 | 1.33 |
Fiscal Year End for SCYNEXIS, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 73 | 81 | 75 | 88 | 86 |
Receivables | 0 | 0 | 0 | 2 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 13 | 10 |
Other Current Assets | 21 | 21 | 27 | 25 | 47 |
Total Current Assets | 95 | 102 | 102 | 129 | 146 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 11 | 14 | 24 | 17 | 6 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 108 | 118 | 128 | 149 | 155 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 13 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 9 | 7 | 3 | 3 |
Current Portion Long-Term Debt | 0 | 12 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 6 | 5 | 8 | 10 | 7 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 1 | 3 | 5 |
Total Current Liabilities | 25 | 27 | 16 | 17 | 16 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 3 | 2 | 1 |
Convertible Debt | 0 | 0 | 12 | 12 | 12 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 18 | 22 | 24 | 30 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 47 | 44 | 55 | 57 | 62 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 430 | 429 | 428 | 428 | 427 |
Retained Earnings | -369 | -355 | -355 | -336 | -334 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 60 | 74 | 73 | 92 | 93 |
Total Liabilities & Shareholder's Equity | 108 | 118 | 128 | 149 | 155 |
Total Common Equity | 60 | 74 | 73 | 92 | 93 |
Shares Outstanding | 37.70 | 37.70 | 37.20 | 37.10 | 36.50 |
Book Value Per Share | 1.60 | 1.97 | 1.96 | 2.48 | 2.55 |